On Oct 2, Janssen Provided Written Notice To Dyadic That It Has Decided To Wind Down Collaboration With An Effective End Date Of Dec 31, 2023
Portfolio Pulse from Benzinga Newsdesk
Janssen, a subsidiary of Johnson & Johnson, has provided written notice to Dyadic that it will end its collaboration with the company, effective Dec 31, 2023, according to an SEC filing.
October 06, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Johnson & Johnson's subsidiary Janssen is ending its collaboration with Dyadic, which may affect JNJ's future projects.
The termination of the collaboration may affect JNJ's future projects and strategies. However, the overall impact on JNJ's stock price is uncertain as it depends on the significance of the collaboration to JNJ's operations.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Dyadic received notice from Janssen about the termination of their collaboration, which could impact Dyadic's future operations.
The termination of the collaboration with Janssen could have a negative impact on Dyadic's future operations and strategies. This could potentially lead to a decrease in DYAI's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90